Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning
SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology recently announced a strategic partnership with
Loading...

SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology recently announced a strategic partnership with
APHRANEL Global Launch Meeting: Code Breaker, World Maker SHANGHAI, April 9, 2025 /PRNewswire/ -- On May 8,
BANGKOK, Jan. 14, 2026 /PRNewswire/ -- The inaugural "Moyom Biotech • Aphranel Global Expert Advisory
SHANGHAI, May 21, 2025 /PRNewswire/ -- On May 8, 2025, Shanghai Moyom Biotechnology Co., Ltd. unveiled its
——The World's First Precisely Regulated Injectable CaHA Filler, Accelerating Compliance in the Medical
PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics
The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the
BEIJING, June 10, 2025 /PRNewswire/ -- From June 6 to 8, 2025, IMCAS Asia was successfully held in Bangkok,
Continue reading uninterrupted with a subscription